posted on 2019-09-12, 18:35authored byYou-Sheng Cai, Cong Wang, Congkui Tian, Wen-Ting Sun, Ling Chen, Di Xiao, Si-Yuan Zhou, Guofu Qiu, Jianqing Yu, Kongkai Zhu, Sheng-Ping Yang
Two octahydro-protoberberine alkaloids,
alangiifoliumines A (1) and B (2), and two
new protoemetine derivatives,
alangiifoliumines C (3) and D (4), together
with 11 known compounds, have been isolated from the stems of Alangium salviifolium. While the structures of these compounds
were elucidated by spectroscopic methods, the absolute configurations
of the new alkaloids were determined by conformational analysis and
time-dependent density functional theory–electronic circular
dichroism spectra calculations on selected stereoisomers. Compounds 1 and 2 represent the first 5,8,8a,9,12,12a,13,13a-octahydro-protoberberine
derivatives, in which the aromatic ring D was reduced to cyclohexene.
All the compounds isolated were evaluated for their cytotoxic activity
against three human cancer cell lines: A-549, HeLa, and SKOV-3. Alkaloids 1, 3, and 6–14 exhibited inhibitory effects against all three human cancer cell
lines, with half-maximal inhibitory concentration (IC50) values in the range of 3 nM to 9.4 μM.